Cancer of the rectum: comparison of two different surgical approaches.

Surgical treatment of rectal cancer is still controversial as regards the type of operation and the extent of lymphadenectomy. Four hundred and fifty-eight patients with rectal cancer operated on at two different hospitals (206 patients, Surgical Department, S. Martino General Hospital and 252 patients, Surgical Department, Galliera General Hospital) in the decade 1980-1989 were studied.

Colorectal cancer metastases: surgical indications and multimodal approach.

Background/aims: The therapeutic plan to follow in patients affected by hepatic and pulmonary metastases from colorectal cancer is based on prognostic factors and staging.

Methodology: Our experience from January 1980 to January 2002 underlines the effectiveness of combined multimodal therapy in the treatment of advanced metastatic stages. A total of 224 patients with metastases from colorectal cancer have been treated.

[Anterior resection in rectal cancer: the role of lymphadenectomy. Comparison of 2 surgical experiences].

Of great interest today is the debate regarding the benefits and limitations of extended lymphadenectomy in rectal cancer, particularly with regard to patient survival. In the present report we review the experience of two different surgical departments: a total of 458 patients with rectal cancer were operated on in the 1st Surgical Department of S. Martino Hospital, Genoa, and in the 1st Surgical Department of Galliera Hospital, Genoa over the period from 1980 to 1989.

[A prospective study of 106 patients with hemorrhoids treated with PPH stapler. Early and long-term results].

Muco-mucosal resection with a PPH stapler according to Longo allows repair of arterial hyperaemia, venous dilation and mucosal prolapse. From September 1 1997 to October 31 2000 a prospective study was conducted in 106 patients. The results show that the Longo haemorrhoidectomy technique is well tolerated and almost painless, and is characterised by a low complication rate and good results in the long term.

[Combined multimodal treatment for liver and lung metastasis from colorectal cancer: a new therapeutic option?].

The authors analyse which therapeutic strategy to adopt on the basis of prognostic factors and staging of hepatic and pulmonary metastases from colorectal cancer. They underline the effectiveness of combined multimodal therapy in the treatment of very advanced metastatic stages. 218 patients with metastases from colorectal cancer (12 pulmonary and 206 hepatic metastases) were treated from January 1980 to October 2000.